Literature DB >> 27000246

A clinical study on closing-in in focal brain-damaged individuals.

Natascia De Lucia1, Dario Grossi1, Luigi Trojano2.   

Abstract

In visuo-constructional assessment, brain-damaged individuals may copy figures near to or superimposed on the model, showing the Closing-in (CI). CI has been largely investigated in dementia, and often ascribed to impairments of the attention/executive abilities ("Attraction hypothesis"). Only a few dated studies investigated frequency of CI in brain-damaged individuals, without clarifying the genesis of the phenomenon. We aimed at testing the "Attraction hypothesis" in 27 individuals with focal frontal cortical or sub-cortical brain lesions by a dual-task experimental paradigm. The participants underwent a neuropsychological battery and a copying task to be performed alone (single task condition), or concurrently with a simple or a complex verbal secondary task (dual-task conditions). CI was found in 66% of frontal-damaged individuals, who scored significantly lower than healthy adults on all neuropsychological measures; brain-damaged individuals showing CI performed worse than frontal-damaged individuals without CI on frontal and visuo-constructional measures. In the dual-task condition with the complex secondary task CI was significantly enhanced, with a weaker tendency to self-correction, in individuals with CI compared to individuals without CI. These findings would confirm that the CI in brain-damaged individuals is related to reduction of attentional resources, consistently with the "Attraction hypothesis".
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Attention; Closing-in; Drawing; Dual-task; Focal damage; Frontal lobe

Mesh:

Year:  2016        PMID: 27000246     DOI: 10.1016/j.jns.2016.02.059

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  1 in total

1.  Constructional apraxia from the roots up: Kleist, Strauss, and their contemporaries.

Authors:  Luigi Trojano
Journal:  Neurol Sci       Date:  2019-12-09       Impact factor: 3.307

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.